{"id":"W2532960187","doi":"10.1182/blood.v120.21.153.153","title":"Mature Results From ECOG Study E1405 – A Phase II Study of VcR-CVAD with Maintenance Rituximab for Previously Untreated Mantle Cell Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Regimen; Rituximab; Bortezomib; Mantle cell lymphoma; Vincristine; Internal medicine; Surgery; Cyclophosphamide; Maintenance therapy; Chemotherapy regimen; Phases of clinical research; Gastroenterology; Urology; Chemotherapy; Multiple myeloma; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009495229,0.001042388,0.001734285,0.00046144,0.0003389307,0.001136274,0.001109935,0.001410683,0.002422403],"category_scores_gemma":[0.002191458,0.000358119,0.001334268,0.0005245443,0.0008219308,0.0006943995,0.0004002288,0.00222458,0.0005944456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009877076,"about_ca_system_score_gemma":0.001493105,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001108629,"about_ca_topic_score_gemma":0.002564624,"domain_scores_codex":[0.9967566,0.002464389,0.0001509169,0.000177455,0.0002163693,0.0002342687],"domain_scores_gemma":[0.9979059,0.000619429,0.0002910527,0.0002284989,0.0001473752,0.0008077923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7860953,0.03087997,0.02517973,0.001165867,0.004486744,0.0004319394,0.0003346039,0.003186971,0.03009463,0.0005153008,0.007672943,0.109956],"study_design_scores_gemma":[0.4665219,0.4494852,0.06759427,0.0001314519,0.001391379,0.0003330301,0.00006896455,0.0009141155,0.003978612,0.0002934028,0.009241471,0.00004619599],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752346,0.00827722,0.001082369,0.0009393368,0.0001776976,0.004168049,0.003375067,0.0001113746,0.00663445],"genre_scores_gemma":[0.9813665,0.001771334,0.002011664,0.001976388,0.0002349163,0.002152918,0.008131806,0.00005325403,0.002301315],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009495229,"threshold_uncertainty_score":0.0502162,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01537323677415164,"score_gpt":0.2680676121240122,"score_spread":0.2526943753498606,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}